Literature DB >> 22180101

A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach.

Jaafar N Haidar1, Qing-An Yuan, Lin Zeng, Mark Snavely, Xenia Luna, Haifan Zhang, Wei Zhu, Dale L Ludwig, Zhenping Zhu.   

Abstract

Antibody (Ab) humanization is crucial to generate clinically relevant biologics from hybridoma-derived monoclonal antibodies (mAbs). In this study, we integrated antibody structural information from the Protein Data Bank with known back-to-mouse mutational data to build a universal consensus of framework positions (10 heavy and 7 light) critical for the preservation of the functional conformation of the Complimentarity Determining Region of antibodies. On the basis of FR consensus, we describe here a universal combinatorial library suitable for humanizing exogenous antibodies by CDR-grafting. The six CDRs of the murine anti-human EGFR Fab M225 were grafted onto a distinct (low FR sequence similarity to M225) human FR sequence that incorporates at the 17 FR consensus positions the permutations of the naturally observed amino acid diversities. Ten clones were selected from the combinatorial library expressing phage-displayed humanized M225 Fabs. Surprisingly, 2 of the 10 clones were found to bind EGFR with stronger affinity than M225. Cell-based assays demonstrated that the 10 selected clones retained epitope specificity by blocking EGFR phosphorylation and thus hindering cellular proliferation. Our results suggest that there is a universal and structurally rigid near-CDR set of FR positions that cooperatively support the binding conformation of CDRs.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180101     DOI: 10.1002/prot.23246

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  16 in total

1.  Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.

Authors:  Sue Townsend; Brian J Fennell; James R Apgar; Matthew Lambert; Barry McDonnell; Joanne Grant; Jason Wade; Edward Franklin; Niall Foy; Deirdre Ní Shúilleabháin; Conor Fields; Alfredo Darmanin-Sheehan; Amy King; Janet E Paulsen; Timothy P Hickling; Lioudmila Tchistiakova; Orla Cunningham; William J J Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

Review 2.  Advances in Antibody Design.

Authors:  Kathryn E Tiller; Peter M Tessier
Journal:  Annu Rev Biomed Eng       Date:  2015-08-14       Impact factor: 9.590

3.  Humanized mouse G6 anti-idiotypic monoclonal antibody has therapeutic potential against IGHV1-69 germline gene-based B-CLL.

Authors:  De-Kuan Chang; Vinodh B Kurella; Subhabrata Biswas; Yuval Avnir; Jianhua Sui; Xueqian Wang; Jiusong Sun; Yanyan Wang; Madhura Panditrao; Eric Peterson; Aimee Tallarico; Stacey Fernandes; Margaret Goodall; Quan Zhu; Jennifer R Brown; Roy Jefferis; Wayne A Marasco
Journal:  MAbs       Date:  2016-03-10       Impact factor: 5.857

4.  Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examples.

Authors:  Yi-Fan Zhang; Mitchell Ho
Journal:  MAbs       Date:  2017-02-06       Impact factor: 5.857

5.  Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody.

Authors:  Sonia Covaceuszach; Sara Marinelli; Ivet Krastanova; Gabriele Ugolini; Flaminia Pavone; Doriano Lamba; Antonino Cattaneo
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

6.  Humanized-VHH transbodies that inhibit HCV protease and replication.

Authors:  Surasak Jittavisutthikul; Jeeraphong Thanongsaksrikul; Kanyarat Thueng-In; Monrat Chulanetra; Potjanee Srimanote; Watee Seesuay; Aijaz Ahmad Malik; Wanpen Chaicumpa
Journal:  Viruses       Date:  2015-04-20       Impact factor: 5.048

Review 7.  The structural basis of antibody-antigen recognition.

Authors:  Inbal Sela-Culang; Vered Kunik; Yanay Ofran
Journal:  Front Immunol       Date:  2013-10-08       Impact factor: 7.561

8.  Cell penetrable human scFv specific to middle domain of matrix protein-1 protects mice from lethal influenza.

Authors:  Fonthip Dong-din-on; Thaweesak Songserm; Tippawan Pissawong; Potjanee Srimanote; Jeeraphong Thanongsaksrikul; Kanyarat Thueng-in; Pattra Moonjit; Preeda Lertwatcharasarakul; Watee Seesuay; Wanpen Chaicumpa
Journal:  Viruses       Date:  2015-01-14       Impact factor: 5.048

9.  Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody.

Authors:  Weixu Meng; Aimin Tang; Xiaohua Ye; Xun Gui; Leike Li; Xuejun Fan; Robbie D Schultz; Daniel C Freed; Sha Ha; Dai Wang; Ningyan Zhang; Tong-Ming Fu; Zhiqiang An
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

10.  Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma.

Authors:  Yi-Fan Zhang; Mitchell Ho
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.